Vector BioPharma
Vector BioPharma focuses on developing targeted gene therapies using adeno-associated virus (AAV) vectors for rare genetic diseases affecting the central nervous system and liver.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $30M
About
Vector BioPharma focuses on developing targeted gene therapies using adeno-associated virus (AAV) vectors for rare genetic diseases affecting the central nervous system and liver.
Gene TherapyRare DiseaseGenetics & Genomics
Funding History
1Total raised:$30M
Venture$30M